Pharma supply shortages drive calls for more integrated supply chains
Drug maker Pfizer sounded the alarm on 11 June that it would be running out ...
By Mike Weir
For months, humanity has been drip-fed endless minutiae on subjects most never previously cared about, such as phased clinical trials, and pioneering mRNA vaccine technology.
But one of the puzzles of this phase of the pandemic is how little we know about how vaccines are going to be distributed.
Recap
On the practicalities of transporting all that science from distant pharma factories into the bloodstreams of billions via bare and expectant arms, we have heard little.
Given the unprecedented enormity of the task, this ...
Comment on this article